Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Biocon, Gland Pharma, Mphasis and Bandhan Bank may move out, says note by Nuvama Alternative & Quantitative Research

Adani Power, Varun Beverages, ABB ripe for Nifty Next50 inclusion

Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2260 in its research report dated November 30, 2022.

Buy Gland Pharma; target of Rs 2260: Sharekhan

Lack of near-term visibility on profitability for the core business is another concern about Indian firm

Gland Pharma stock seen underperforming after acquiring France’s Cenexi

Stocks to watch out for today: Wipro, Britannia Industries, Cipla, Biocon, Gland Pharma, Kilpest India and more

Stocks in news: Wipro, Britannia Industries, Cipla, Biocon and more

Gland Pharma’s Cenexi may constitute 25 per cent of the combined entity’s FY2024E sales and 15 per cent of Ebitda, said Kotak Institutional Equities

Gland Pharma Cenexi acquisition: Rs 1,800 or Rs 2,500, where is the stock headed?

Gland Pharma’s management expects to close the transaction by February/March 2023 and to fund the deal through internal accruals

Analysts largely neutral on Gland Pharma’s acquisition of Cenexi Group

Easy Trip Planners Ltd, Rail Vikas Nigam Ltd, Gland Pharma Ltd and New India Assurance Company Ltd are among the other losers in the BSE’s ‘A’ group today, 30 November 2022.

Indian Railway Finance Corporation Ltd leads losers in ‘A’ group

The acquisition provides Gland Pharma access to leading know-how and development capabilities in sterile forms including for ophthalmic gel, needleless injectors and hormones, the company said

Gland Pharma enters into agreement to acquire Cenexi; stock slips 5%

The generic injectable focused CDMO company has a strategic focus on expanding its CDMO offerings in the European market and build a manufacturing presence in the market.

Gland Pharma arm acquires 100% stake of Cenexi Group

Stocks to watch: Zomato, NDTV, Gland Pharma, Biocon, Bandhan Bank, IDFC, Bandhan Bank, Inox Wind, Aditya Sun Life AMC, Klipest and RattanIndia

Stocks that will see action on November 30, 2022

Wipro: Wipro announced that it is an official launch partner for Amazon Security Lake from Amazon Web Service (AWS), which provides the modern enterprise with intelligent security data to solve more security use cases, increase security visibility

Wipro, Biocon, Zomato, Gland Pharma in focus

Gland Pharma is engaged in manufacturing small volume parenterals (SVPs) and contract development services.

Gland Pharma Ltd

Gland Pharma Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Adani Power, Varun Beverages, ABB ripe for Nifty Next50 inclusion

Buy Gland Pharma; target of Rs 2260: Sharekhan

Gland Pharma stock seen underperforming after acquiring France’s Cenexi

Stocks in news: Wipro, Britannia Industries, Cipla, Biocon and more

Gland Pharma Cenexi acquisition: Rs 1,800 or Rs 2,500, where is the stock headed?

Analysts largely neutral on Gland Pharma’s acquisition of Cenexi Group

Indian Railway Finance Corporation Ltd leads losers in ‘A’ group

Gland Pharma enters into agreement to acquire Cenexi; stock slips 5%

Gland Pharma Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Adani Power, Varun Beverages, ABB ripe for Nifty Next50 inclusion

Buy Gland Pharma; target of Rs 2260: Sharekhan

Gland Pharma stock seen underperforming after acquiring France’s Cenexi

Stocks in news: Wipro, Britannia Industries, Cipla, Biocon and more

Gland Pharma Cenexi acquisition: Rs 1,800 or Rs 2,500, where is the stock headed?

Analysts largely neutral on Gland Pharma’s acquisition of Cenexi Group

Indian Railway Finance Corporation Ltd leads losers in ‘A’ group

Gland Pharma enters into agreement to acquire Cenexi; stock slips 5%

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock